Planta Med 2014; 80(13): 1067-1071
DOI: 10.1055/s-0034-1382999
Original Papers
Georg Thieme Verlag KG Stuttgart · New York

Antihyperlipidemic Effects of Rhapontin and Rhapontigenin from Rheum undulatum in Rats Fed a High-Cholesterol Diet

Autoren

  • Sung-Pil Jo

    1   Department of Public Health Science (BK21 PLUS Program), Graduate School, Korea University, Seoul, Republic of Korea
  • Jeong-Keun Kim

    2   Department of Chemical Engineering and Biotechnology, Korea Polytechnic University, Shihung-si, Gyeonggi-do, Republic of Korea
  • Young-Hee Lim

    1   Department of Public Health Science (BK21 PLUS Program), Graduate School, Korea University, Seoul, Republic of Korea
    3   Department of Laboratory Medicine, Korea University Guro Hospital, Seoul, Republic of Korea
Weitere Informationen

Publikationsverlauf

received 08. April 2014
revised 21. Juli 2014

accepted 29. Juli 2014

Publikationsdatum:
15. August 2014 (online)

Abstract

Rhapontin was purified from a methanol extract from the roots of Rheum undulatum, and rhapontigenin was produced by an enzymatic transformation of rhapontin. Rats were fed a high-cholesterol diet to induce hyperlipidemia, followed by oral treatment with rhapontin or rhapontigenin (1–5 mg/kg/day). Rhapontin and rhapontigenin treatment resulted in a significant (p < 0.05) dose-dependent decrease in the serum lipid level, while the high-density lipoprotein cholesterol level increased slightly compared with the experimental control. Furthermore, rhapontin and rhapontigenin treatment improved the pathological characteristics of the degenerating fatty liver in high-cholesterol diet-induced hyperlipidemic rats dose-dependently. Aspartate aminotransferase and alanine aminotransferase levels in rhapontin- and rhapontigenin-treated hyperlipidemic rats were not significantly different from those in the control. These results indicate that rhapontin and rhapontigenin can be used as potent antihyperlipidemic agents.